← Leaderboards
Bryce Alan Jones
Georgetown University
$187,348
Attributed
$187,348
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$187,348 · 1
By mechanism
F30$187,348 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Moshe Levi$17,675,566
- Christopher S Wilcox$17,361,029
- Michael D Johnson$2,313,593
- Esther Braselmann$2,251,370
- Nils Axel Fredrik Palm$837,000
Others in their field
Other Emerging Leaders on “Acids”
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,259,745
- Bala Raja · Luminostics, Inc.$28,624,460
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,132,807
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Dave Beebe · Flambeau Diagnostics Llc$16,670,000
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
AcidsAgonistArginineAdrenal GlandsBindingBiochemicalBiological Adaptation To StressBiopsyBile AcidsChronic Kidney FailureClinical TrialsCollagenCollagen Type IvDefectDiabetic NephropathyDietDimethylargininaseDisease ProgressionBlood PressureDrug RepurposingEffective TherapyEtiologyFda ApprovedFemale
Grant awards (4)
Obeticholic acid as a novel treatment for Alport syndrome$49,566
F30 · FY2024 · DK · contact PI
Obeticholic acid as a novel treatment for Alport syndrome$52,694
F30 · FY2023 · DK · contact PI
Obeticholic acid as a novel treatment for Alport syndrome$51,752
F30 · FY2022 · DK · contact PI
Obeticholic acid as a novel treatment for Alport syndrome$33,336
F30 · FY2021 · DK · contact PI